MDMA-assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach
Mathew Herbert, Brian H. Blanco, Dimitri Perivoliotis, Jason B. Luoma, Gisele Fernandes-Osterhold, Andrew W. Bismark, Joshua Woolley
September 7, 2025 preprint DOI: 10.31234/osf.io/7xyfq_v1 via OpenAlex
Summary
AI-generated from the abstractMDMA-assisted psychotherapy shows promise for treating PTSD, but the FDA rejected its current form due to concerns about standardization and empirical grounding of the psychotherapy methods. Acceptance and Commitment Therapy (ACT), an evidence-based cognitive behavioral therapy, is proposed as a well-suited alternative to pair with MDMA. The subjective effects of MDMA directly support key ACT processes; ACT methods could prepare patients for MDMA administration, guide therapists during sessions, and help integrate MDMA experiences to improve functioning and quality of life. ACT offers a scalable, structured yet flexible framework for a new PTSD treatment approach.
Study at a glance
| Characteristics | Theoretical or philosophical paper |
|---|---|
| Interventions | MDMA-assisted psychotherapy Acceptance and Commitment Therapy |
| Topics | MDMA |
| Keywords | Standardization Posttraumatic stress Cognition Psychotherapist |
| Key finding | Acceptance and Commitment Therapy is particularly well-suited to be integrated with MDMA for treating PTSD, addressing concerns about standardization and empirical basis. |
Abstract
There is promise for 3,4-Methylenedioxymethamphetamine (MDMA)-assistedpsychotherapy as a highly effective and durable treatment for posttraumatic stress disorder(PTSD). However, the Food and Drug Administration rejected MDMA-assisted psychotherapy inits current form, expressing concerns about the lack of standardization and empirical basis ofpsychotherapy methods. This highlights the need to consider alternative psychotherapeuticapproaches to integrate with MDMA for the treatment of PTSD. We propose that the evidencebased cognitive behavioral therapy, Acceptance and Commitment Therapy (ACT), is particularlywell-suited to be paired with the administration of MDMA for PTSD. Specifically: 1) thesubjective effects of MDMA directly support key ACT processes; 2) ACT methods could helpprepare patients for MDMA administration, increasingly the likelihood of efficacy andtolerability; 3) ACT provides a “process-directed” approach to assist the therapist and help thepatient during MDMA administration sessions; and 4) ACT may help optimize the integration ofMDMA experiences to shape adaptive functioning and promote quality of life followingtreatment. We provide examples of how ACT methods could be used for many of these goals. Insum, we believe ACT provides a highly scalable, structured yet flexible, evidence-basedframework well-suited to be integrated with MDMA as a new treatment approach for PTSD.